TABLE 1

Interday variation of % remaining of ethynylestradiol (50 μM) as a MBI-positive reference and ketoconazole (100 nM) as a MBI-negative reference in the automated CYP3A MBI screening using each substrate

The interday data were obtained from the average of the % remaining data from several different studies in duplicate on three different days.



Midazolam

Nifedipine

Testosterone

Ethynylestradiol
Ketoconazole
Ethynylestradiol
Ketoconazole
Ethynylestradiol
Ketoconazole
% remaining
Days 3 3 3 3 3 3
Mean 33.7 108.0 35.7 112.3 46.9 101.8
S.D. 4.0 6.7 2.7 6.0 5.9 5.8
CV
12.0
6.2
7.4
5.3
12.5
5.7